Acute Myeloid Leukemia Clinical Trials in Suzhou, Jiangsu
27 recruitingSuzhou, Jiangsu, China
Showing 1–20 of 27 trials
Recruiting
Phase 2
Study on the Efficacy and Safety of the TmBU Conditioning Regimen in High-risk or Relapsed/Refractory Acute Leukemia
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaTransplantation, Stem Cell+1 more
The First Affiliated Hospital of Soochow University48 enrolled1 locationNCT06816134
Recruiting
Phase 2
VAC Regimen for AML Patients Who Failed to Response to VA Regimen
Acute Myeloid Leukemia
The First Affiliated Hospital of Soochow University32 enrolled1 locationNCT06220162
Recruiting
Phase 2
Maintenance Therapy of Hypomethylating Agent (HMA) in Favorable Risk Acute Myeloid Leukemia (AML) Patients
Acute Myeloid Leukemia
The First Affiliated Hospital of Soochow University77 enrolled1 locationNCT06379360
Recruiting
Phase 1Phase 2
Venetoclax Plus Hypomethylating Agents and Subcutaneous Cytarabine for CEBPA-Mutated AML
Acute Myeloid Leukemia (AML)CEBPA MutationUnfit, New-diagnosis AML
The First Affiliated Hospital of Soochow University29 enrolled1 locationNCT07451912
Recruiting
Phase 1Phase 2
A Study of BGB-11417 in Participants With Myeloid Malignancies
Acute Myeloid LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasm
BeiGene260 enrolled46 locationsNCT04771130
Recruiting
Phase 2
Alternating Regimen of VA and Low-dose CHA in the Treatment of Unfit Newly Diagnosed AML
Newly Diagnosed Acute Myeloid Leukemia (AML)Intensive Chemotherapy UnfitAge ≥60
First Affiliated Hospital of Zhejiang University25 enrolled5 locationsNCT07172204
Recruiting
Phase 2
CAV Regimen for R/R AML
Acute Myeloid Leukemia
The First Affiliated Hospital of Soochow University68 enrolled1 locationNCT05657639
Recruiting
Phase 2
Comparison of VA (Venetoclax, Azacitidine), VACl (VA, Cladribine), VACh (VA, Chidamide), and Alternating VACl/VACh in Newly Diagnosed Acute Myeloid Leukemia
Acute Myeloid Leukemia, AdultNewly Diagnosed
The First Affiliated Hospital of Soochow University172 enrolled1 locationNCT06532552
Recruiting
Not Applicable
PD-1 Inhibitor, Azacitidine and Low-dose DLI in AML Relapse After Allo-HSCT
Acute Myeloid Leukemia
The First Affiliated Hospital of Soochow University43 enrolled1 locationNCT05772273
Recruiting
Phase 2
Study of A Venetoclax-based, Anthracycline-free Regimen in Newly Diagnosed CBFβ::MYH11(+) AML
Acute Myeloid Leukemia
The First Affiliated Hospital of Soochow University40 enrolled2 locationsNCT06429098
Recruiting
Phase 1
A Study of GLB-001 in Patients With Myeloid Malignancies
Acute Myeloid LeukemiaMyelodysplastic SyndromesMyelofibrosis+3 more
Hangzhou GluBio Pharmaceutical Co., Ltd.108 enrolled14 locationsNCT06378437
Recruiting
Phase 3
A Study to Evaluate HMPL-306 in Patients With IDH1or IDH2-mutated Acute Myeloid Leukemia
Acute Myeloid Leukemia
Hutchmed316 enrolled53 locationsNCT06387069
Recruiting
Phase 1Phase 2
A New Treatment of Newly Diagnosed KIT Mutation CBF-Acute Myeloid Leukemia
Acute Myeloid Leukemia With T(8;21)(Q22;Q22)Acute Myeloid Leukemia With T(16;16)(P13;Q22)KIT Gene Mutation+1 more
The First Affiliated Hospital of Soochow University78 enrolled1 locationNCT07028073
Recruiting
Phase 2
a New Treatment of Newly Diagnosed IDH1 Mutation Acute Myeloid Leukemia
Acute Myeloid LeukemiaIDH1 Gene MutationIvosidenib
The First Affiliated Hospital of Soochow University42 enrolled1 locationNCT07007949
Recruiting
Phase 2
A Study of HYML-122 and Cytarabine in Patients With FLT3 Positive Relapsed or Refractory Acute Myeloid Leukemia (AML)
Relapsed or Refractory Acute Myeloid Leukemia (AML)
Tarapeutics Science Inc.18 enrolled1 locationNCT05241093
Recruiting
Not Applicable
A Single-arm, Prospective Study of TBI + BUMEL As a Conditioning Regimen for Salvage HSCT in Patients with R/R AML
Relapsed or Refractory Acute Myeloid Leukemia
The First Affiliated Hospital of Soochow University40 enrolled1 locationNCT06879847
Recruiting
Phase 3
Randomized Study of Conditioning of Fludarabine Combined With Single or Dual Alkylating Agents in Myeloid Malignancies
Acute Myeloid LeukemiaMyelodysplastic Syndromes
Shanghai Jiao Tong University School of Medicine222 enrolled9 locationsNCT05991908
Recruiting
Early Phase 1
Evaluation of the Safety and Efficacy of Human CI-135 (FLT3) Targeted CAR-T Cells Injection for Subjects with Relapsed/Refractory Acute Myeloid Leukemia
Acute Myeloid Leukemia (AML)
Hrain Biotechnology Co., Ltd.7 enrolled1 locationNCT06760260
Recruiting
Phase 1Phase 2
BN104 in Combination With Chemotherapy or Targeted Agents for Acute Myeloid Leukemia
Acute Myeloid Leukemia
Chen Suning135 enrolled1 locationNCT06746519
Recruiting
Phase 1
A Phase Ib Study of APG-115 Single Agent or in Combination With Azacitidine or Cytarabine in Patients With AML and MDS.
Acute Myeloid Leukemia (AML)Myelodysplastic Syndromes (MDS)
Ascentage Pharma Group Inc.102 enrolled14 locationsNCT04275518